RedHill Biopharma Ltd. (RDHL) — Dilution Risk Analysis

Current Snapshot

RedHill Biopharma Ltd. (RDHL) has a DilutionWatch score of 62/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
50,923,261,000 Source

Dilution Risk Score

Score: 62/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: 4 2, EFFECT 1, 424B5 1, 6-K 3, 3 3.

FormFiledAccession
4 2026-07-13 0001178913-26-003473
EFFECT 2026-07-13 9999999995-26-002275
424B5 2026-06-29 0001178913-26-003349
6-K 2026-06-22 0001178913-26-003296
6-K 2026-06-22 0001178913-26-003290
6-K 2026-06-18 0001178913-26-003248
4 2026-04-22 0001178913-26-002183
3 2026-03-19 0001178913-26-001548
3 2026-03-18 0001178913-26-001269
3 2026-03-18 0001178913-26-001272

Dilution Risk Drivers

DriverStored ValueSource
ATM offering capacity remaining $2,128,000 Source
Three-year share count growth 299.5% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 62/10) Source
ATM Offering Capacity Remaining
$2,128,000 Source
Share Count Growth (3-Year)
299.5% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.